CARE Ratings Ltd
CARE Ratings Ltd (CARERATING) last reported results for the quarter ended Jun 2026, with sales of ₹112 crore and net profit of ₹33 crore. The stock last traded at ₹1,605, a market capitalisation of ₹4,833 crore, on a P/E of 27.2. Over the past 52 weeks the stock has ranged between ₹1,393 and ₹1,838. Figures are as of 6 Oct 2026 and are not real time.
CARE Ratings Ltd share price and key metrics
- Current price
- ₹1,605
- Market cap
- ₹4,833 cr
- Stock P/E
- 27.2
- Book value
- ₹310
- ROE
- 19.7%
- ROCE
- 26.3%
- Dividend yield
- 1.37%
- 52w high / low
- 1838/1393
Metrics as of 6 Oct 2026. Not real time.
Track CARE Ratings Ltd
Cruxal reads every CARE Ratings Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
CARE Ratings Ltd growth and returns
- 10 Years
- 5%
- 5 Years
- 14%
- 3 Years
- 19%
- TTM
- 18%
- 10 Years
- 4%
- 5 Years
- 14%
- 3 Years
- 27%
- TTM
- 25%
- 10 Years
- 1%
- 5 Years
- 19%
- 3 Years
- 23%
- 1 Year
- 9%
- 10 Years
- 19%
- 5 Years
- 16%
- 3 Years
- 18%
- Last Year
- 20%
CARE Ratings Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹112 cr, up 19.1% from ₹94 cr a year earlier. Net profit was ₹33 cr, up 26.9% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 117 | 96 | 110 | 94 | 136 | 112 | 131 | 112 |
| Expenses | 62 | 66 | 62 | 66 | 68 | 72 | 70 | 77 |
| Operating profit | 56 | 30 | 47 | 28 | 68 | 40 | 61 | 35 |
| OPM % | 47% | 32% | 43% | 30% | 50% | 36% | 46% | 31% |
| Other income | 12 | 12 | 15 | 14 | 13 | 13 | 16 | 15 |
| Interest | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 4 |
| Profit before tax | 64 | 39 | 59 | 37 | 77 | 49 | 72 | 45 |
| Tax % | 27% | 27% | 26% | 29% | 26% | 25% | 26% | 27% |
| Net profit | 47 | 28 | 43 | 26 | 57 | 37 | 53 | 33 |
| EPS (₹) | 15.41 | 9.29 | 14.24 | 8.61 | 18.89 | 11.96 | 17.58 | 10.73 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
CARE Ratings Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 287 | 333 | 319 | 244 | 248 | 248 | 279 | 332 | 402 | 473 | 491 |
| Operating profit | 182 | 211 | 175 | 81 | 96 | 80 | 99 | 112 | 155 | 197 | 204 |
| OPM % | 63% | 63% | 55% | 33% | 39% | 32% | 36% | 34% | 39% | 42% | 42% |
| Net profit | 148 | 162 | 138 | 83 | 91 | 77 | 85 | 103 | 140 | 174 | 180 |
| EPS (₹) | 50.13 | 55.13 | 46.66 | 27.96 | 30.39 | 25.34 | 28.12 | 33.67 | 45.85 | 56.97 | 59.16 |
TTM is the trailing twelve months to the most recent quarter.
CARE Ratings Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 29 | 29 | 29 | 29 | 29 | 30 | 30 | 30 | 30 | 30 |
| Reserves | 491 | 567 | 521 | 504 | 559 | 618 | 643 | 687 | 776 | 902 |
| Borrowings | 0 | 0 | 0 | 0 | 7 | 9 | 17 | 20 | 24 | 26 |
| Other liabilities | 64 | 61 | 64 | 85 | 74 | 69 | 80 | 105 | 128 | 146 |
| Total liabilities | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 | 1,105 |
| Fixed assets | 61 | 60 | 83 | 93 | 85 | 96 | 107 | 109 | 119 | 122 |
| CWIP | 0 | 0 | 0 | 1 | 3 | 8 | 4 | 6 | 3 | 5 |
| Investments | 466 | 518 | 439 | 339 | 240 | 44 | 44 | 44 | 134 | 87 |
| Other assets | 57 | 79 | 93 | 185 | 343 | 577 | 614 | 683 | 702 | 890 |
| Total assets | 584 | 658 | 614 | 618 | 671 | 725 | 770 | 842 | 958 | 1,105 |
As reported by the company. Total assets equal total liabilities by construction.
CARE Ratings Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 119 | 134 | 109 | 67 | 86 | 68 | 82 | 91 | 123 | 148 |
| Cash from investing | -22 | -25 | 83 | 27 | -38 | -27 | 13 | -39 | -58 | -94 |
| Cash from financing | -96 | -99 | -195 | -107 | -43 | -35 | -63 | -63 | -54 | -59 |
| Net cash flow | 1 | 11 | -4 | -13 | 5 | 6 | 32 | -11 | 11 | -6 |
| Free cash flow | 118 | 131 | 82 | 63 | 82 | 49 | 71 | 82 | 108 | 140 |
| CFO / operating profit | 101% | 95% | 98% | 125% | 114% | 122% | 115% | 119% | 112% | 107% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
CARE Ratings Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 44% | 41% | 35% | 19% | 21% | 16% | 19% | 21% | 25% | 26% |
| Debtor days | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 | 29 | 27 |
| Cash conversion cycle | 32 | 43 | 54 | 61 | 31 | 25 | 27 | 25 | 29 | 27 |
| Working capital days | -10 | -1 | 13 | 14 | -3 | 635 | 638 | 591 | 451 | 316 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
CARE Ratings Ltd shareholding pattern
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| FIIs | 24.79% | 24.75% | 23.75% | 24.62% | 23.61% | 23.00% | 23.25% | 23.41% |
| DIIs | 25.28% | 27.50% | 29.38% | 29.76% | 31.60% | 31.30% | 31.38% | 31.58% |
| Public | 49.92% | 47.74% | 46.87% | 45.61% | 44.79% | 45.70% | 45.37% | 45.01% |
| No. of shareholders | 53,602 | 52,007 | 51,395 | 61,111 | 56,931 | 59,139 | 58,978 | 58,466 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
CARE Ratings Ltd corporate filings
- CARE Ratings Allots 14,200 Equity Shares via ESOP on October 5, 2026Company Updatelow impact
Cruxal's analysis: CARE Ratings Ltd issued 14,200 new equity shares through exercise of ESOPs on October 5…
Read the full analysis - Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018Company Updatelow impact
- Closure of Trading WindowInsider Trading / SASTlow impact
- CARE Ratings Ltd announces scheduled investor meetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding an upcoming analyst/investor meet…
Read the full analysis - CARE Ratings Ltd announces intimation of investor meetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has filed an intimation regarding an upcoming analyst/investor meet. The…
Read the full analysis - CARE Ratings Ltd announces scheduled investor meet for September 2026Company Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding an upcoming analyst/investor meet…
Read the full analysis - CARE Ratings Ltd: Disclosure of Newspaper Publication under Regulation 30Company Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has filed a copy of its newspaper publication as per Regulation 30 of…
Read the full analysis - CARE Ratings Ltd announces scheduled investor meetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding an upcoming analyst/investor meet…
Read the full analysis - CARE Ratings Ltd announces cancellation of scheduled investor meetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has formally notified the exchange regarding the cancellation of a…
Read the full analysis - CARE Ratings Ltd allots 24,500 equity shares under ESOP schemeCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has announced the allotment of 24,500 equity shares following the…
Read the full analysis - CARE Ratings Ltd announces upcoming investor meetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding a scheduled analyst/investor meet…
Read the full analysis - CARE Ratings Ltd announces intimation of investor meetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued a formal intimation regarding an upcoming analyst/investor…
Read the full analysis - CARE Ratings Ltd announces rescheduling of investor meetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding the rescheduling of a previously…
Read the full analysis - CARE Ratings Ltd announces upcoming analyst/investor meetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding an upcoming analyst/investor meeting…
Read the full analysis - CARE Ratings Ltd announces upcoming investor meetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding an upcoming analyst/investor meet…
Read the full analysis - CARE Ratings Ltd announces upcoming investor meetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding an upcoming analyst/investor meet…
Read the full analysis - CARE Ratings Ltd announces upcoming investor meetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding an upcoming analyst/investor meet…
Read the full analysis - CARE Ratings Limited reports financial results for the quarter ended June 30, 2026Company Updatelow impact
Cruxal's analysis: CARE Ratings Limited has published its financial results for the quarter ended June 30…
Read the full analysis - CARE Ratings Ltd announces scheduled investor meetCompany Updatelow impact
Cruxal's analysis: CARE Ratings Ltd has issued an intimation regarding a scheduled analyst/investor meet…
Read the full analysis - CARE Ratings Limited Reports Robust Q1 FY27 Financials with 18.9% Consolidated Revenue GrowthCompany Updatehigh impact
Cruxal's analysis: CARE Ratings Limited delivered a strong performance for the quarter ended June 30, 2026…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.